Glycoproteomic characterization of butyrylcholinesterase from human plasma.
about
Clinical Glycomics Employing Graphitized Carbon Liquid Chromatography-Mass SpectrometryEnhanced detection and identification of glycopeptides in negative ion mode mass spectrometry.Plant-derived human butyrylcholinesterase, but not an organophosphorous-compound hydrolyzing variant thereof, protects rodents against nerve agentsResistance of human butyrylcholinesterase to methylene blue-catalyzed photoinactivation; mass spectrometry analysis of oxidation products.Oligomerization status influences subcellular deposition and glycosylation of recombinant butyrylcholinesterase in Nicotiana benthamiana.A Microarray-Matrix-assisted Laser Desorption/Ionization-Mass Spectrometry Approach for Site-specific Protein N-glycosylation Analysis, as Demonstrated for Human Serum Immunoglobulin M (IgM).Distinguishing N-acetylneuraminic acid linkage isomers on glycopeptides by ion mobility-mass spectrometry.Transient Expression of Tetrameric Recombinant Human Butyrylcholinesterase in Nicotiana benthamiana.Analytical performance of immobilized pronase for glycopeptide footprinting and implications for surpassing reductionist glycoproteomicsHuman carboxylesterases HCE1 and HCE2: ontogenic expression, inter-individual variability and differential hydrolysis of oseltamivir, aspirin, deltamethrin and permethrin.Expression of human butyrylcholinesterase with an engineered glycosylation profile resembling the plasma-derived orthologueTherapeutic plasma proteins--application of proteomics in process optimization, validation, and analysis of the final product.Molecular Assembly and Biosynthesis of Acetylcholinesterase in Brain and Muscle: the Roles of t-peptide, FHB Domain, and N-linked Glycosylation.Glycoengineering of Esterase Activity through Metabolic Flux-Based Modulation of Sialic Acid.Class I alpha-mannosidases are required for N-glycan processing and root development in Arabidopsis thaliana.Quantum dot labeling of butyrylcholinesterase maintains substrate and inhibitor interactions and cell adherence features.In vitro ability of currently available oximes to reactivate organophosphate pesticide-inhibited human acetylcholinesterase and butyrylcholinesterase.A model of glycosylated human butyrylcholinesterase.Bacterial Expression of Human Butyrylcholinesterase as a Tool for Nerve Agent Bioscavengers Development.Biochemical, molecular and preclinical characterization of a double-virus-reduced human butyrylcholinesterase preparation designed for clinical use.In vitro oxime-assisted reactivation of paraoxon-inhibited human acetylcholinesterase and butyrylcholinesterase.Structural analysis of human glycoprotein butyrylcholinesterase using atomistic molecular dynamics: The importance of glycosylation site ASN241.Determination of site-specific glycan heterogeneity on glycoproteins.Proline-Rich Chaperones Are Compared Computationally and Experimentally for Their Abilities to Facilitate Recombinant Butyrylcholinesterase Tetramerization in CHO Cells.
P2860
Q27024150-DC9327BC-EC3F-4B96-B405-585466DC8E02Q30991632-B06E6935-568B-4C55-9781-BA3380093F09Q34377206-C89050ED-057B-4646-B5C0-2A65DCA94323Q34471002-0C515444-AA54-4788-AD60-321AB517AD67Q34693466-AD11D573-79BE-4026-84EC-29764831710CQ35584921-E526B829-1BCB-4E8A-97A6-3671352521F5Q35939622-73C60FFE-29AC-4FEB-8C3B-4AA72BAEB8D5Q37009481-8F12167C-199F-4DB3-85AB-393BA344CC3EQ37087199-9203727D-04A3-4528-81DB-7AA0243E087BQ37163881-33BFC6D1-8FF6-4B71-85CD-277AE6D25E63Q37684636-4AB4316E-3ED0-470C-A9B0-2B102E4129B3Q37872258-35B755B5-0197-4471-A355-5DDC23D965DAQ37951933-73E7D6E6-10DC-46D4-94E1-1FE2E0F666BDQ38715644-4ABFBAB0-1393-4633-96F4-3C8E7BF8EDFCQ39761286-AAD33CB0-ABA6-4EDD-BA88-D5F67044ECADQ41880996-F2BCE523-9004-4556-891A-5827928EB325Q42102550-56A0443D-C50C-459C-B369-014722BD3D49Q42416154-A7CFD5F4-FC53-43E2-85EB-ED8D1521E86FQ45071150-5993C2A4-D9C1-4B4F-BB2D-D56E8DBD3E69Q45372375-E8C362AF-007F-4854-B05F-3956781BF34EQ45935496-97C9BADF-20B3-4946-BA40-A49041DEBD07Q45964090-3511A05D-865E-417F-8245-CA096390AAD1Q47650180-47702097-24AD-4F9A-8DFE-05991B3F3C69Q48197665-88CB8148-14A3-4F42-834E-24C425BA6858
P2860
Glycoproteomic characterization of butyrylcholinesterase from human plasma.
description
2008 nî lūn-bûn
@nan
2008 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Glycoproteomic characterization of butyrylcholinesterase from human plasma.
@ast
Glycoproteomic characterization of butyrylcholinesterase from human plasma.
@en
Glycoproteomic characterization of butyrylcholinesterase from human plasma.
@nl
type
label
Glycoproteomic characterization of butyrylcholinesterase from human plasma.
@ast
Glycoproteomic characterization of butyrylcholinesterase from human plasma.
@en
Glycoproteomic characterization of butyrylcholinesterase from human plasma.
@nl
prefLabel
Glycoproteomic characterization of butyrylcholinesterase from human plasma.
@ast
Glycoproteomic characterization of butyrylcholinesterase from human plasma.
@en
Glycoproteomic characterization of butyrylcholinesterase from human plasma.
@nl
P2093
P50
P356
P1433
P1476
Glycoproteomic characterization of butyrylcholinesterase from human plasma.
@en
P2093
Alfred Weber
Hans-Peter Schwarz
Hartmut Ehrlich
Johannes Stadlmann
Wolfgang Teschner
P2860
P304
P356
10.1002/PMIC.200700720
P577
2008-01-01T00:00:00Z